Phase II Trial of Sterotactic Body Radiation Therapy (SBRT) for Unresectable Liver Metastases from Colorectal Carcinoma
Annually 10 - 30% of the 140,000 colorectal cancer patients diagnosed will have liver metastasis. Many of these will be unresectable. Chemotherapy is effective in treating metastatic colorectal cancer, but is unlikely to lead to cure.
Stereotactic body radiation therapy (SBRT) refers to radiation therapy delivered precisely with a high dose volume conforming closely to the tumour, usually in less than 10 treatment fractions.
See Trial Summary
Print this page and take it to your doctor to discuss your eligibilty and treatment options. Only your doctor can refer you to a clinical trial.
These resources are provided in partnership with the
Canadian Cancer Society